AJP - Lung Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Am J Physiol Lung Cell Mol Physiol (January 20, 2006). doi:10.1152/ajplung.00301.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/L1238    most recent
00301.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lajoie-Kadoch, S.
Right arrow Articles by Hamid, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lajoie-Kadoch, S.
Right arrow Articles by Hamid, Q.
Submitted on July 13, 2005
Accepted on January 13, 2006

TNF{alpha} and IFN{gamma} inversely modulate expression of the IL-17E receptor in Airway Smooth Muscle Cells

Stephane Lajoie-Kadoch1, Philippe Joubert1, Severine Letuve1, Andrew J Halayko2, James G Martin1, Abdellilah Soussi-Gounni3, and Qutayba Hamid1*

1 Meakins-Christie Laboratories, McGill University, Montreal, Quebec, Canada
2 Departement of Physiology, University of Manitoba, Winnipeg, Manitoba, Canada
3 Departement of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada

* To whom correspondence should be addressed. E-mail: qutayba.hamid{at}mcgill.ca.

The interleukin-17B receptor (IL-17BR) is expressed in a variety of tissues and is upregulated under inflammatory conditions. This receptor binds both its cognate ligand IL-17B and IL-17E/IL-25, a novel cytokine known to promote Th2 responses. The present study illustrates that airway smooth muscle cells express IL-17BR in vitro and that its expression is upregulated by TNF{alpha} and downregulated by IFN{gamma}. Our data indicates that TNF{alpha} upregulates IL-17BR mainly through NF-{kappa}B as assessed with the IKK2 inhibitor, AS602868. In addition, both IFN{gamma} and dexamethasone are able to antagonize a TNF{alpha}-induced IL-17BR increase in mRNA expression. The MEK inhibitor, U0126, totally reversed the inhibition observed with IFN{gamma}, suggesting the involvement of the ERK pathway in this effect. In addition, upon stimulation with IL-17E, ASMC increase their expression of extracellular matrix components, namely pro-collagen {alpha}1 and lumican mRNA. Furthermore, immunohistochemical analysis of biopsies from asthmatic subjects reveals that this receptor is abundant in smooth muscle layers. This is the first report showing IL-17BR receptor in structural cells of the airways. Our results suggest a potential pro-remodelling effect of IL-17E on airway smooth muscle cells through the induction of extracellular matrix and that its receptor is upregulated by proinflammatory conditions.




This article has been cited by other articles:


Home page
 Proc Am Thorac SocHome page
O. Tliba and Y. Amrani
Airway Smooth Muscle Cell as an Inflammatory Cell: Lessons Learned from Interferon Signaling Pathways
Proceedings of the ATS, January 1, 2008; 5(1): 106 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Keslacy, O. Tliba, H. Baidouri, and Y. Amrani
Inhibition of Tumor Necrosis Factor-{alpha}-Inducible Inflammatory Genes by Interferon-{gamma} Is Associated with Altered Nuclear Factor-{kappa}B Transactivation and Enhanced Histone Deacetylase Activity
Mol. Pharmacol., February 1, 2007; 71(2): 609 - 618.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.